As­tex vet Neil Thomp­son looks to build dis­cov­ery from scratch at rare dis­ease AI up­start out of Cam­bridge, UK

As a co-in­ven­tor of silde­nafil — a pill orig­i­nal­ly de­signed to treat coro­nary hy­per­ten­sion — David Brown knows how big of an im­pact drug hunters can make when they take a ther­a­py be­ing used to treat one dis­ease and di­rect it to an­oth­er. Af­ter 40 years in the in­dus­try, re­pur­pos­ing is at the cen­ter of his lat­est rare dis­ease ven­ture at Healx.

And now, step­ping the gas ped­al on new dis­cov­ery projects, Brown has re­cruit­ed Neil Thomp­son as the Cam­bridge, UK-based start­up’s new CSO.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER